The Shotlee Journal
Kesehatan & Kebugaran: Kesehatan Metabolik
Artikel tentang obat GLP-1, terapi peptida, dan penurunan berat badan.
Artikel Terbaru
Loading articles...
Kesehatan & Kebugaran
Berobenatide Pfizer: Hasil Fase 2b Menjanjikan untuk Penurunan Berat Badan
Pfizer's investigational GLP-1 receptor agonist, berobenatide, has shown promising results in Phase 2b trials for weight loss. This article delves into the data, its implications for obesity treatment, and what it means for Pfizer's investment outlook.
Shotlee··7 menit membaca
